We are focused on elevating the next era of obesity care by advancing a diversified pipeline to provide options for people living with obesity no matter where they are in their treatment journey.
Our Approach
With an obesity-first focus, our pipeline is specifically designed to address critical needs in the current therapeutic landscape.
Our Pipeline
Kailera’s four clinical-stage product candidates leverage multiple GLP-1- based mechanisms of action and routes of administration.
Our Clinical Trials
Learn about Kailera’s ongoing clinical trials for people living with obesity.
